Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19330
Title: Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Administration, Oral,Adult,Aged,Alopecia/chemically induced,Antineoplastic Agents, Phytogenic/administration &,dosage/blood/*pharmacokinetics/*toxicity,Biological Availability,Camptothecin/administration & dosage/*analogs &,derivatives/blood/*pharmacokinetics/*toxicity,Drug Administration Schedule,Female,Hematologic Diseases/chemically induced,Humans,Male,Metabolic Clearance Rate,Middle Aged,Neoplasms/*drug therapy
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19330
ISSN: 1078-0432
Link: http://www.ncbi.nlm.nih.gov/pubmed/14519632
http://clincancerres.aacrjournals.org/content/9/11/4101.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Gelderblom-2003-Phase I pharmacologi.pdf190.48 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons